Epizyme, Inc. is a clinical stage biopharmaceutical company that focuses on developing epigenetic therapies for cancer patients. The company's product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases (HMTs). Epizyme's proprietary technology allows it to discover and develop novel drugs targeting these enzymes, which are known to play a critical role in cancer growth and progression. With a pipeline of promising drug candidates, Epizyme is well-positioned to address unmet medical needs in oncology, helping to advance the fight against cancer.
Epizyme Inc's ticker is EPZM
The company's shares trade on the NASDAQ stock exchange
They are based in Cambridge, Massachusetts
There are 51-200 employees working at Epizyme Inc
It is http://www.epizyme.com/
Epizyme Inc is in the Healthcare sector
Epizyme Inc is in the Biotechnology industry
The following five companies are Epizyme Inc's industry peers: